MEDP
Medpace Holdings Inc
NASDAQ: MEDP · HEALTHCARE · DIAGNOSTICS & RESEARCH
$413.59
+0.96% today
Updated 2026-04-29
Market cap
$11.81B
P/E ratio
26.04
P/S ratio
4.41x
EPS (TTM)
$15.88
Dividend yield
—
52W range
$284 – $629
Volume
0.4M
WallStSmart proprietary scores
66
out of 100
Grade: B
Buy
Investment rating
8.7
Growth
A5.0
Quality
C+9.0
Profitability
A+4.0
Valuation
C—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$442.83
+7.07%
12-Month target
$460.23
+11.28%
Intrinsic (DCF)
$402.51
Margin of safety
-5.32%
1 Strong Buy3 Buy8 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 77.20% — strong efficiency
+ Free cash flow $144.97M — positive
+ Revenue growth 26.50% QoQ
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.46B | $1.89B | $2.11B | $2.53B | $2.68B |
| Net income | $245.37M | $282.81M | $404.39M | $451.12M | $123.87M |
| EPS | — | — | — | — | $15.88 |
| Free cash flow | $351.17M | $396.73M | $572.27M | $681.87M | $144.97M |
| Profit margin | 16.81% | 15.00% | 19.17% | 17.83% | 17.20% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | MCCARTHY, CORNELIUS P. III | Sale | 29 | — |
| 2026-03-31 | MCCARTHY, CORNELIUS P. III | Buy | 29 | — |
| 2026-03-31 | KRAFT, ROBERT O. | Sale | 33 | — |
Peer comparison
Smart narrative
Medpace Holdings Inc trades at $413.59. representing a P/E of 26.04x trailing earnings. Our Smart Value Score of 66/100 indicates the stock is good. TTM revenue stands at $2.68B. with profit margins at 17.20%. Our DCF model estimates intrinsic value at $402.51.
Frequently asked questions
What is Medpace Holdings Inc's stock price?
Medpace Holdings Inc (MEDP) trades at $413.59.
Is Medpace Holdings Inc overvalued?
Smart Value Score 66/100 (Grade B, Buy). DCF value $402.51.
What is the price target of Medpace Holdings Inc (MEDP)?
The analyst target price is $442.83, representing +7.1% upside from the current price of $413.59.
What is the intrinsic value of Medpace Holdings Inc (MEDP)?
Based on our DCF model, intrinsic value is $402.51, a -5.3% margin of safety versus $413.59.
What is Medpace Holdings Inc's revenue?
TTM revenue is $2.68B.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.41x
ROE77.20%
Beta1.39
50D MA$468.41
200D MA$511.43
Shares out0.03B
Float0.02B
Short ratio—
Avg volume0.4M
Performance
1 week+5.13%
1 month-13.87%
3 months-30.26%
YTD-26.36%
1 year—
3 years—
5 years—